Enterprise

Nvidia's Falling Gross Margin Signals Pricing Power Shift to Memory Makers

The chip giant's Q2 guidance points to rising memory costs, creating a tailwind for suppliers like Micron Technology.

Omega Editorial· August 29, 2026· 3 min read

Nvidia's latest quarterly results delivered staggering growth figures — $96.2 billion in total revenue, more than double the year-ago period — but the most consequential detail for the broader AI supply chain emerged in the company's forward guidance. Management expects gross margins to compress from 75% to between 71% and 72% by the fourth quarter, and executives explicitly attributed the decline to rising memory costs.

That margin pressure represents a fundamental shift in bargaining power within the AI infrastructure stack. As Nvidia scales production of its most advanced GPUs, the company is paying premium prices for the high-bandwidth memory modules that sit alongside those processors. This dynamic creates a direct pricing tailwind for memory manufacturers, particularly Micron Technology, which supplies the specialized DRAM and NAND products required for AI workloads.

Why it matters

Nvidia's margin guidance offers a rare window into cost structure shifts within the AI hardware ecosystem. When the dominant player in AI chips signals that a key input is commanding higher prices, it validates the investment thesis for upstream suppliers. For memory makers that have struggled with cyclical pricing pressure in recent years, Nvidia's acknowledgment that memory is driving margin compression confirms that AI demand is creating genuine pricing power — not just volume growth.

Data center segment now exceeds Nvidia's total 2023 revenue

The scale of Nvidia's data center business has reached a threshold that redefines the company's profile. The segment alone generated $89 billion in the quarter, surpassing what Nvidia produced across all product lines just one year earlier. Hyperscale customers — the cloud providers building out AI infrastructure at massive scale — contributed $48.7 billion, up 102% year over year.

Operating income reached $63.7 billion, up 124% from the prior year, while net income came in at $59.7 billion, or $2.46 per diluted share. The company's third-quarter revenue guidance of $108 billion (plus or minus 2%) assumes no compute sales to China, yet still represents sequential growth that few companies at Nvidia's scale can sustain.

Memory costs drive margin outlook lower

Nvidia's GAAP and non-GAAP gross margins both came in at 75% for the second quarter. For the third quarter, management guided both metrics to 74%, with expectations that margins will bottom between 71% and 72% in the fourth quarter before recovering in fiscal 2028. The company's CFO attributed the decline specifically to memory pricing, according to details first reported by AI Watch.

This guidance matters because it quantifies the cost pressure Nvidia faces as it sources high-bandwidth memory for its Hopper and Blackwell architectures. The premium Nvidia is paying reflects tight supply conditions for advanced memory products, which require specialized manufacturing processes and capacity that cannot be added quickly. For investors evaluating memory suppliers, Nvidia's margin compression serves as confirmation that pricing leverage has shifted.

The details of Nvidia's fiscal 2027 second-quarter results and forward guidance were first reported by AI Watch.

#nvidia#micron technology#ai chips#memory pricing#gross margin#data center

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise

Enterprise· 4 min read

Dr. Martens Rebuilt Customer Service From Scratch After Years of Decline

The footwear brand consolidated fragmented systems across regions onto Salesforce and AWS, reversing a three-year slide in customer satisfaction within months.

Via Automation Watch · Sep 24, 2026
Enterprise· 4 min read

AI Coding Tools Added $942M to Hospital Bills Without Care Changes

Blue Cross Blue Shield Association analysis finds hospitals using automation to classify more cases as complex, driving up costs with no documented increase in treatment intensity.

Via AI Watch · Sep 24, 2026
Enterprise· 4 min read

AI Clinical Trial Endpoints Fail at Scale Without Data Harmonization

Analysis of over one million patient screenings reveals that AI validation in single sites masks critical performance drift across multi-site deployments.

Via AI Watch · Sep 24, 2026